Alcon introduced the Clareon PanOptix Pro trifocal IOL, which will be commercially available in the U.S. in May, for patients ...
Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected ...
SightMD proudly announces that Dr. Jeffrey Martin is one of the first ophthalmologists on Long Island to implant the revolutionary Clareon PanOptix Pro, the latest multifocal intraocular lens (IOL) ...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, announced today the introduction of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract ...
Clareon® PanOptix® Pro Trifocal IOL will also be available in the Clareon®AutonoMe® preloaded delivery system “As the global leader in eye care, we are committed to improving our ...
The global implantable collamer lens market is set to experience remarkable expansion in the coming decade, driven by the increasing adoption of minimally invasive vision correction procedures. Market ...
Clareon PanOptix Pro provides unprecedented 94% light utilization, resulting in half the light scatter of Clareon PanOptix 1,2,§,* Clareon PanOptix Pro provides more uninterrupted light ...
Phakic IOL technologies have undergone substantial improvements in recent years, with progressive upgrades in design and material and more accurate sizing strategies.At the ESCRS winter meeting, Erik ...
KeyBanc analyst Brett Fishbin raised the firm’s price target on Alcon (ALC) to $112 from $108 on higher multiple, while keeping an Overweight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback